Recon: J&J sued over employer liability for overpaying for drugs; Lilly terminates Verzenio Phase 3 trial for prostate cancer
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States